STE vs THAR · P/E 25, rev $5.46B vs $187.4M cap
STERIS plc (STE) versus Tharimmune Inc. (THAR) — a side-by-side from cached financials, not a winner call.
STERIS plc (STE) is a medical devices company listed on NYSE.
Tharimmune Inc. (THAR) is a biotechnology company listed on NASDAQ.
Latest reported STE revenue for 2025-03-31 was $5.46B. Net income was $616.1M. Revenue was up 284.6% from 2024-03-31 to 2025-03-31. STE currently screens at market cap $19.43B and trailing P/E 25.1.
THAR does not have a complete income-statement cache yet.
STE currently screens at market cap $19.43B and trailing P/E 25.1. THAR currently screens at market cap $187.4M.
Not investment advice. Open the STE and THAR stock pages for the full models.
Not investment advice.